A carregar...

Reduction of endothelial dysfunction following VEGF gene therapy

BACKGROUND/OBJECTIVES: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. VEGF gene therapy improves perfusion of ischaemic myocardium in experimental models and possibly in patients with end-stage coronary artery disease. In addition to its proliferative and migratory effect o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tio, R.A., Wijpkema, J., Tan, E.S., Asselbergs, F.W., Hospers, G.A.P., Jessurun, G.A.J., Zijlstra, F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2497290/
https://ncbi.nlm.nih.gov/pubmed/25696473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!